Venus Concept Inc (VERO) Stock

DelistedNasdaq: VEROVenus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally.

0.31
Final close · Apr 6, 2026

VERO is no longer traded. Venus Concept was delisted from the Nasdaq in April 2026.

Prices on this page are historical; the last trade was April 6, 2026 at $0.31.

Venus Concept stock price history

Split-adjusted closes, 2012–2026

VERO final trading statistics

Final close
$0.31
Final trading day
Apr 6, 2026
Market cap at delisting
$578.2K
Shares outstanding
1.86M
Final 52-week range
$0.25 – $14.50
Avg. volume (final 3 mo.)
5,793,560
All-time high (split-adj.)
$24552.03 · Oct 2017
All-time low (split-adj.)
$0.30 · Apr 2026
Return since IPO
-100.0%
Beta
-0.06
Book value / share
$1.44
Price / book
0.22
Final 52 wk
0.2514.50

Venus Concept earnings per share

Earnings per share

Venus Concept revenue & net income

RevenueNet income

Venus Concept annual financials

Venus Concept Inc revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2024$64.83M-$47.0M-$17.17
FY2023$76.35M-$37.2M-$6.85
FY2022$99.50M-$43.7M-$0.65
FY2021$105.62M-$22.1M-$0.47
FY2020$78.01M-$82.8M-$1.64

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Venus Concept Inc

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

Venus Concept stock FAQ

What happened to Venus Concept stock?

Venus Concept stock was delisted from the Nasdaq. Its final close was $0.31 on April 6, 2026.

Is VERO stock still trading?

No. VERO was delisted from the Nasdaq in April 2026 and no longer trades on a U.S. exchange.

What was the last price of VERO stock?

VERO closed at $0.31 on its final trading day, April 6, 2026, for a market value of about $578.2K.

What were Venus Concept's revenue and earnings in its last full fiscal year?

Venus Concept reported revenue of $64.83M and net income of -$47.0M in fiscal 2024, its last full year as a public company.

When did Venus Concept go public?

Venus Concept Inc stock began trading on November 5, 2012.

Medical Devices stocks to research

All Healthcare stocks →